In today’s world, a significant fear has been created around cholesterol, leading most people to perceive it as an enemy.

To meet predefined lowdensity lipoprotein-cholesterol (LDL ... for baseline values. Both drugs were well tolerated. Conclusion: The results show that atorvastatin has an overall better efficacy ...

Analysis Reveals an Additional Mechanism Behind Statin Therapy's Heart-Related ... of Australians over the age of 50 take cholesterol-lowering drugs to prevent heart disease and strokes, but ...

The findings could lead to more tailored treatments for cardiovascular disease. Scientists at the Institutes of Health (NIH) ...

JE: Human genetic studies provide strong target validation for the role of PCSK9 in modulating LDL cholesterol (LDL-C) levels and the risk of coronary heart disease (CHD).

Rosuvastatin with a 19-h half-life and atorvastatin with ... as adjunctive therapy to medication: Replacing animal protein with soy protein can reduce total cholesterol and LDL-C; 2 g/day of ...

Verve Therapeutics has started dosing patients in a phase 1b trial of its in vivo gene-editing drug for high cholesterol, designed to permanently switch off the PCSK9 gene with a one-shot treatment.

A variant of PCSK9, a gene involved in raising cholesterol, may spur metastasis. An approved antibody might stop it.

Matt Vann can’t recall much about the moment, four years ago, that changed the trajectory of his life. Vann, a San Francisco firefighter, was outside a building on Spear Street near the Embarcadero, ...

The same results have also been found in a meta-analysis evaluating the efficacy and safety of high-intensity statin therapy in patients with CVD with age more than 65 years, which is a risk factor ...